Back to Search
Start Over
Efficacy and Safety of Vixarelimab, a Human Monoclonal Oncostatin M Receptor Beta Antibody, in Moderate-to-Severe Prurigo Nodularis: A Randomised, Double-Blind, Placebo-Controlled Phase 2a Study
- Source :
- SSRN Electronic Journal.
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
Details
- ISSN :
- 15565068
- Database :
- OpenAIRE
- Journal :
- SSRN Electronic Journal
- Accession number :
- edsair.doi...........5a562312c9ffca0c377b140da2138418
- Full Text :
- https://doi.org/10.2139/ssrn.4184786